Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

RANI US Equity

Rani Therapeutics Holdings, Inc.Health Care · Pharmaceutical Preparations · CIK 1856725 · FY ends Dec 31
$0.92
+0.09 (+11.05%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 2 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by RA CAPITAL MANAGEMENT, L.P.sec.gov ↗
2026-08-138-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-048-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-07-3113G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD CAPITAL MANAGEMENT LLCsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-31

Every row is a filed document, checked against its EDGAR index.